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Article 8

L I T E R A T U R E

H I G H L I G H T S
Selected abstracts and commentary

NEURORADIOLOGY
COMMENTARY
All 4 abstracts for this issue are related to stroke. With the increasing use of rTPA for acute ischemic stroke there is
recognition that a subset of patients would be better managed with endovascular techniques to re-establish brain
perfusion. This has led to an increasing interest in the endovascular management of stroke. The pair of review
articles from the April and May issues of American Journal of Neuroradiology focuses on this. The first of the articles
deals with the technical side of the equation; the pharmaceutical agents as well as the mechanical devices. The
second more importantly reviews the evidence for their efficacy. Both reviews are very comprehensive and are
essential reading for all stroke neurologists and neuroradiologists.
The third abstract is a systematic review of the data to support the current wisdom that the lesion as seen on the
diffusion weighted imaging represents the irreversibly infracted tissue. This all of us take to be the absolute truth but
is it? There is disturbingly little high quality evidence to support this widespread belief.
The final abstract provides some support for the current practice of subjecting all patients with intracranial
hemorrhages to CT angiography (CTA). The study demonstrates that CTA is both sensitive and specific for the causes
of these hemorrhages.
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Am J Neuroradiol 30:649-661, April 2009
R.G. Nogueira,a,b L.H. Schwammb and J.A. Hirscha
a Endovascular Neurosurgery/Interventional Neuroradiology Section, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Mass
b Departments of Radiology and Neurosurgery, and Neurocritical Care and Vascular Neurology Section, Department of Neurology, Massachusetts General Hospital, Harvard
Medical School, Boston, Mass

ENDOVASCULAR APPROACHES TO ACUTE STROKE, PART 1: DRUGS, DEVICES, AND DATA
pharmacologic strategies for acute stroke treatment, providing
both a historic context and the state of the art. The drugs will
be classified on the basis of their theoretic rationale for
therapy. Next, we will review the various devices and strategies
for mechanical revascularization with an aim toward
comprehensiveness. These range from wire disruption of
thrombus to preclinical trials for novel mechanical solutions.
This first installment of this 2-part series will end with an
analysis of retrograde reperfusion techniques.

SUMMARY: Despite years of research and pioneering clinical
work, stroke remains a massive public health concern. Since
1996, we have lived in the era of US Food and Drug
Administration-approved intravenous (IV) recombinant tissue
plasminogen activator (rtPA). This treatment, despite its
promise, continues to exhibit its limitations. Endovascular
therapy has several theoretic advantages over IV rtPA,
including site specificity, longer treatment windows, and higher
recanalization rates. In this article, we will review the various

Am J Neuroradiol 30:859-875, May 2009
R.G. Nogueira,a,b A.J. Yooa, F.S. Buonannob and J.A. Hirscha
a Endovascular Neurosurgery/Interventional Neuroradiology Section, Massachusetts General Hospital, Harvard Medical School, Boston, Mass
b Departments of Radiology and Neurosurgery; and Neurocritical Care and Vascular Neurology Section, Department of Neurology, Massachusetts General Hospital, Harvard Medical
School, Boston, Mass

ENDOVASCULAR APPROACHES TO ACUTE STROKE, PART 2: A COMPREHENSIVE REVIEW
OF STUDIES AND TRIALS
substantially lower rates of good outcomes compared with IV
and/or intra-arterial thrombolytic trials. However, such analyses
disregard important differences in clot location and burden,
baseline stroke severity, time from stroke onset to treatment,
and patient selection in these studies. Many clinical trials are
testing novel devices and drugs as well as the paradigm of
physiology-based stroke imaging as a treatment-selection tool.
The objective of this article is to provide a comprehensive
review of the relevant past, current, and upcoming data on
endovascular stroke therapy with a special focus on the
prospective studies and randomized clinical trials.

SUMMARY: Reperfusion remains the mainstay of acute
ischemic stroke treatment. Endovascular therapy has become
a promising alternative for patients who are ineligible for or
have failed intravenous (IV) thrombolysis. The conviction that
recanalization of properly selected patients is essential for the
achievement of good clinical outcomes has led to the rapid
and widespread growth in the adoption of endovascular stroke
therapies. However, comparisons of the recent reperfusion
studies have brought into question the strength of the
association between revascularization and improved clinical
outcome. Despite higher rates of recanalization, the
mechanical thrombectomy studies have demonstrated
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Am J Neuroradiol 30:1206-1212, June-July 2009
P.G. Kranza and J.D. Eastwooda
a From the Department of Radiology, Duke University Medical Center, Durham, NC

DOES DIFFUSION-WEIGHTED IMAGING REPRESENT THE ISCHEMIC CORE? AN EVIDENCEBASED SYSTEMATIC REVIEW
progression, no change, or lesion regression compared with
follow-up imaging. RESULTS: Limited numbers of highly
methodologically rigorous studies (Oxford levels 1 and 2) were
available. There was great variability in observed rates of DWI
lesion reversal (0%-83%), with a surprisingly high mean rate of
DWI lesion reversal (24% of pooled patients). Many studies did
not include sufficient data to determine the precise prevalence of
DWI lesion growth or reversal. CONCLUSIONS: The available
tissue-outcome evidence supporting the hypothesis that DWI is a
surrogate marker for ischemic core in humans is troublingly
inconsistent and merits an overall grade D based on the criteria
set out by the Oxford Centre for Evidence-Based Medicine.

BACKGROUND AND PURPOSE: Diffusion-weighted imaging (DWI)
hyperintensity is hypothesized to represent irreversibly infracted
tissue (ischemic core) in the setting of acute stroke.
Measurement of the ischemic core has implications for both
prognosis and therapy. We wished to assess the level of evidence
in the literature supporting this hypothesis. MATERIALS AND
METHODS: We performed a systematic review of the literature
relating to tissue outcomes of DWI hyperintense stroke lesions in
humans. The methodologic rigor of studies was evaluated by
using criteria set out by the Oxford Centre for Evidence-Based
Medicine. Data from individual studies were also analyzed to
determine the prevalence of patients demonstrating lesion

Am J Neuroradiol 30:1213-1221, June-July 2009
J.E. Delgado Almandoz,a P.W. Schaefer,a N.P. Forero,a J.R. Falla,a R.G. Gonzaleza and J.M. Romeroa
a From the Division of Neuroradiology, Radiology Department, Massachusetts General Hospital, Boston, Mass

DIAGNOSTIC ACCURACY AND YIELD OF MULTIDETECTOR CT ANGIOGRAPHY IN THE
EVALUATION OF SPONTANEOUS INTRAPARENCHYMAL CEREBRAL HEMORRHAGE
evaluation, and pathologic findings was determined, when
available. Multiple-variable logistic regression analysis was
performed to determine clinical and radiologic factors that
predict a higher yield of MDCTA. RESULTS: MDCTA
demonstrated a vascular etiology in 91 patients (14.6%), with a
sensitivity of 96%, specificity of 99%, and diagnostic accuracy of
98%. We found independent, statistically significant higher yields
of MDCTA in patients with the following characteristics: 1) age
younger than 46 years (47%); 2) lobar (20%) or infratentorial
(16%) IPH, especially lobar IPH with associated intraventricular
hemorrhage (25%); 3) female sex (18%); or 4) neither known
hypertension nor impaired coagulation at presentation (33%).
CONCLUSIONS: MDCTA is an accurate diagnostic examination in
the evaluation of adult patients presenting with spontaneous IPH
and should be performed in all patients with the aforementioned
clinical and radiologic characteristics.

BACKGROUND AND PURPOSE: Multidetector CT angiography
(MDCTA) is emerging as the favored initial diagnostic
examination in the evaluation of patients presenting with
spontaneous intraparenchymal hemorrhage (IPH). This study
aims to evaluate the diagnostic accuracy and yield of MDCTA for
the detection of vascular etiologies in adult patients presenting
to the emergency department with IPH. MATERIALS AND
METHODS: We conducted a retrospective study of 623
consecutive adult patients presenting to the emergency
department with IPH, who were evaluated with MDCTA during a
9-year period. CT angiograms were reviewed by 2
neuroradiologists to determine the IPH site and the presence of
a vascular etiology. Patients with associated subarachnoid
hemorrhage in the basal cisterns were excluded from the study.
Medical records were reviewed for risk factors and correlation
with final diagnosis. The diagnostic accuracy of MDCTA
compared with conventional angiography, intraoperative
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